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Abstract
Objective To determine whether supported self management in chronic
obstructive pulmonary disease (COPD) can reduce hospital readmissions
in the United Kingdom.
Design Randomised controlled trial.
Setting Community based intervention in the west of Scotland.
Participants Patients admitted to hospital with acute exacerbation of
COPD.
Intervention Participants in the intervention group were trained to detect
and treat exacerbations promptly, with ongoing support for 12 months.
Main outcome measures The primary outcome was hospital
readmissions and deaths due to COPD assessed by record linkage of
Scottish Morbidity Records; health related quality of life measures were
secondary outcomes.
Results 464 patients were randomised, stratified by age, sex, per cent
predicted forced expiratory volume in 1 second, recent pulmonary
rehabilitation attendance, smoking status, deprivation category of area
of residence, and previous COPD admissions. No difference was found
in COPD admissions or death (111/232 (48%) v 108/232 (47%); hazard
ratio 1.05, 95% confidence interval 0.80 to 1.38). Return of health related
quality of life questionnaires was poor (n=265; 57%), so that no useful
conclusions could be made from these data. Pre-planned subgroup
analysis showed no differential benefit in the primary outcome relating
to disease severity or demographic variables. In an exploratory analysis,
42% (75/150) of patients in the intervention group were classified as
successful self managers at study exit, from review of appropriateness
of use of self management therapy. Predictors of successful self
management on stepwise regression were younger age (P=0.012) and
living with others (P=0.010). COPD readmissions/deaths were reduced
in successful self managers compared with unsuccessful self managers
(20/75 (27%) v 51/105 (49%); hazard ratio 0.44, 0.25 to 0.76; P=0.003).
Conclusion Supported self management had no effect on time to first
readmission or death with COPD. Exploratory subgroup analysis
identified a minority of participants who learnt to self manage; this group
had a significantly reduced risk of COPD readmission, were younger,
and were more likely to be living with others.
Trial registration Clinical trials NCT 00706303.
Introduction
Self management has a well established evidence base for
asthma and has been actively investigated as a useful strategy
forpatientswithchronicobstructivepulmonarydisease(COPD),
with a growing evidence base for beneficial and unhelpful
practices.
1-3Itaimstodeveloppatients’copingskillstomaintain
as active a lifestyle as possible, promote correct use of drugs,
and encourage the early identification of increasing symptoms
heralding an exacerbation, so that these can be treated early.
Early treatment of exacerbations has been shown to reduce
morbidity and effect on quality of life.
4 Case management is a
relatedtechniqueforthesupportofpatientswithchronicdisease,
concentratingontheprovisionofsupportbyhealthprofessionals
sothatpatientscanobtainpromptandappropriateaccesstocare
fortheirhealthrelatedproblems.Thisapproachhasbeenshown
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Research
RESEARCHto be beneficial in chronic heart failure but not definitively in
COPD.
5
At the time this study started, the evidence base for self
managementforCOPDpatientswasweak.
6Morerecentstudies,
which have mostly used a combined approach involving
elements of both self management training and case
management, have been more robust and shown benefits.
2 No
randomised controlled studies have been done in the UK
healthcare system.
Acute exacerbations of COPD are the most common cause of
emergency respiratory admission.
7 The 2008 national COPD
audit reported a 90 day readmission rate of 34%.
8 This imposes
a considerable burden on patients and on the health service, in
terms of workload and cost.
4 9 This study therefore set out to
test whether combined self management and case management
(supported self management) could reduce readmissions to
hospital in patients with COPD who had been admitted with
acute exacerbations of COPD in the west of Scotland.
Methods
Participant recruitment and randomisation
EligiblepatientswerethosewithCOPDwhohadbeenadmitted
to hospital with an acute exacerbation of COPD. We defined
COPD as chronic irreversible airflow limitation with forced
expiratoryvolumeinonesecond(FEV1)lessthan70%predicted
and a FEV1/forced vital capacity ratio of less than 70%. Forced
vital capacity is defined as the total amount of air that can be
expelled from the chest by a forced expiratory manoeuvre. We
excluded patients with a history of asthma or left ventricular
failure, which might cause confusion about the cause of
breathlessness; evidence of active malignant disease, which
could influence mortality; or any evidence of confusion/poor
memory, assessed with the abbreviated mental test (scores of
9/10 or 10/10 required).
10 We identified potentially eligible
patients during or shortly after their hospital admission in all
six acute Glasgow hospitals and contributing Lanarkshire
hospitals to which eligible patients with a Glasgow postcode
were admitted. We augmented this by reviewing patients
attending pulmonary rehabilitation and crosschecking for
evidence of hospital admission.
Wegaveorsentpotentiallyeligiblepatientsastudyinformation
leaflet and then contacted them, usually by telephone, to
establish their interest in participation. We made a home visit
to check eligibility and to enrol and subsequently randomise
the patient, if appropriate.
We used a minimisation technique to stratify randomisation of
participants by demographic factors (deprivation category of
area of residence,
11 age and sex, FEV1 per cent predicted at the
time of randomisation, smoking status, participation in
pulmonary rehabilitation within two years, and number of
previous admissions) to control for key aspects of disease
severity and predictors of readmission. We constructed a
computer generated sequence by using the method of
randomisedpermutedblocksoflengthfour,withtwoallocations
being made at random and two by minimisation. Treatment
group allocations were obtained by telephone, after baseline
assessments had been made. This registered the participant on
thesystem,andaresearcherenteredthecharacteristicsnecessary
for the minimisation algorithm by using an interactive voice
response system. The researcher did not know whether a
participant was being allocated at random or by minimisation
and could therefore not determine the next treatment allocation
before enrolling each participant.
Study protocol
All participants had their long term treatment optimised and
inhalertechniquecheckedandwereofferedappropriatesmoking
cessation advice and pulmonary rehabilitation if this had not
beendonewithintheprevioustwoyears.
12Participantsreceived
monthlytelephonecallsfromanindependentresearcher,blinded
to the patients’ randomisation status, to collect information on
health service usage and exacerbations. They were asked to
complete daily diary cards and the questionnaires described
below at six and 12 months and reminded to complete these at
the time of the appropriate monthly telephone call and return
them by prepaid postage. Diary cards were based on those of
Woolhouse et al (box 1).
13
Participants in the intervention group received supported self
management.Studynurses’trainingwasbasedonselfregulation
theory (box 2; further details available from corresponding
author).
14Theinterventionaimedtoempowerpatientstomanage
their COPD independently by improving their understanding
ofdiseaseandmonitoringofsymptomsandbydevelopingtheir
confidence to carry out appropriate actions, such as altering
treatment early in the evolution of an exacerbation or initiating
contact with their usual medical attendant. Self management
materialsbasedontheLivingWellwithCOPDprogrammeand
previouslyadaptedfortheUKpopulationandhealthcaresetting
by an iterative process, were used (Sue Mason, personal
communication).
15 Web appendix A shows an example.
Participantsreceivedfour40minuteindividualtrainingsessions
athomefromastudynurse,fortnightlyoveratwomonthperiod,
with further home visits at least every six weeks (but more
frequentlyonrequest)thereafterforatotalof12months.Nurses
showed patients how to use their symptom diary cards to
recognise deteriorating symptoms and activate their self
management plan. Follow-up visits were patient centred, based
on individual needs as well as reviewing and reinforcing basic
self management messages on the basis of diary card content.
We used Anthonisen’s criteria for characterisation of acute
exacerbations of COPD,
16 defining an exacerbation as a 2 point
change from the participant’s normal level of breathlessness
and sputum colour and quantity or the development of new
upper airway symptoms for two consecutive days. We defined
the end of an exacerbation as a return of respiratory symptoms
to baseline for three days. Participants were trained to identify
and treat exacerbations associated with a 2 point deterioration
insputumcolourwithantibiotic(amoxicillin500mgthreetimes
dailyoroxytetracycline500mgfourtimesdailyforsevendays)
and those associated with increased breathlessness, mucoid
sputum, or upper airway symptoms with prednisolone 25 mg
for five days. This dose was a compromise between the
convenience of the 25 mg tablet and the higher doses used for
established exacerbations,
12 together with the use of treatment
earlier in an exacerbation, taking account of the possibility that
participants would overuse treatment with its associated side
effects.
The control group continued to be managed by their general
practitioner, hospital based specialists, or both (including the
use of emergency out of hours services and the NHS 24 hour
helpline).
Outcome measures
The primary end point was the time to first acute hospital
admissionwithanexacerbationofCOPDordeathduetoCOPD
within 12 months of randomisation. The participant’s usual
medical attendant decided on the need for hospital admission,
independentlyofthestudyteam.TheInformationandStatistics
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RESEARCHBox 1: Diary card assessment of symptoms
Breathing (1=better than usual, 2=normal/usual, 3=worse than usual, 4=much worse than usual
Colour of sputum (using chart with five grades of colour from 1=mucoid to 5=very purulent (deep green))
Amount of sputum produced (0=none, 1=some, up to teaspoonful, 2=a little (tablespoon), 3=moderate (eggcup or more), 4=a lot (cupful
or more)
Type of sputum (1=watery, 2=sticky liquid, 3=semisolid, 4=solid)
Associated symptoms: general wellbeing (1-4), cough (0-3), chest pain (yes/no), cold or flu symptoms (yes/no)
Nocturnal symptoms (0=slept well, 1=woke once because of chest symptoms, 2=woke twice because of chest symptoms, 3=woke more
than twice because of chest symptoms, 5=unable to sleep because of symptoms)
Box 2: Training programme monitoring strategy
Nurses were trained to deliver a structured self management programme in four fortnightly home visits, each lasting about 40 minutes.
During home visits, the nurses discussed:
• The diagnosis of chronic obstructive pulmonary disease (COPD)
• The events that led up to the patient being admitted to hospital
• The nature of exacerbations of COPD, particularly the concept of infective and non-infective exacerbations
• How to recognise the early signs of a developing exacerbation
• How to manage infective and non-infective exacerbations in future, using the diary card to monitor levels of breathlessness and sputum
colour
• How drugs work for the long term treatment and acute exacerbations.
During follow-up visits, in addition to reviewing the above categories, nurses reviewed the patient’s experiences since last seen and used
them as an opportunity to reinforce appropriate self management behaviour and influence unhelpful coping strategies. Information booklets
about COPD (n=6) were left with the patient, together with a contact telephone number for advice during working hours.
Nurses without previous respiratory training completed three half day training sessions, with an equal emphasis on:
• Aspects of COPD pathophysiology and pharmacology
• Communications strategies designed to empower patients (including reinforcing effective strategies, active listening, responding to
patients’ concerns, maintaining interactive conversation).
In addition, observed home interviews took place with one trainer (JC) who used a checklist to record communication behaviours and provide
feedback.
26
Quality assurance of home visits during study
At regular intervals throughout the study, the senior nurse (SL) did paired home visits with study nurses, observing interactions with patients
and scoring these to provide feedback on performance.
Division of the NHS in Scotland independently collated record
linked data on all hospital admissions and deaths for the 12
month period after randomisation for all participants.
Secondary outcome measures were change from baseline at six
and 12 months in St George’s respiratory questionnaire
(SGRQ),
17 in which higher scores indicate greater morbidity;
hospitalanxietyanddepressionscale(HADS),
18inwhichhigher
scores indicate greater likelihood of anxiety or depression;
COPD self-efficacy scale (CSES),
19 in which higher scores
indicate a greater sense of self efficacy; and EuroQol 5D, a
generic quality of life questionnaire,
20 in which larger areas
under the curve indicate better quality of life.
Planned subgroup analyses of differences in the primary end
point between groups defined by the minimisation variables
described earlier aimed to assess the possible effect of these
factors on outcomes. Within the first few months, we realised
that some participants accepted self management more readily
than others. Therefore, as participants in the intervention group
completed their 12 month period of follow up, we classified
them as either a “successful self manager” or not after case
based review by the study team (respiratory specialist, research
registrar, and study nurses) of whether the diary card record
showed a two point deterioration for two consecutive days
before prednisolone, antibiotics, or both were started (assessed
by detailed scrutiny of each patient’s diary card data) and
additional scrutiny of study nurses’ contemporaneous clinical
notes of each patient’s handling of exacerbations. The study
team were blind to information on hospital admissions when
these classifications were made. These were collated
electronically at the end of the study.
Statistical analysis, study numbers, and
power calculation
To achieve 90% power to detect a reduction in the composite
end point of COPD related readmission or death rate from 40%
to 25%, we needed 216 patients per group on the basis of a
continuity corrected χ
2 test for association. We aimed to recruit
250 patients per group, to allow for 13.5% attrition.
Datafortheprimaryoutcome(timetofirstacuteCOPDhospital
admissionordeath)wereavailableforallpatientsandanalysed
with a Cox proportional hazards model adjusting for the
stratification variables. We present results as hazard ratios
(intervention:control) with corresponding 95% confidence
intervals and P values. We considered P values less than 0.05
to be statistically significant. We produced Kaplan-Meier plots
to compare the unadjusted survival rates between the groups.
Weusedanalysisofcovariancemodelstoanalysethesecondary
outcomes (change from baseline in questionnaire scores at 6
and12months),adjustingthemodelsforthebaselinescoreand
stratification variables. We present results as estimated
differences (intervention minus control) with 95% confidence
intervals and P values.
We used Cox proportional hazards models to investigate
differences in the effect of the intervention between subgroups
as determined by the stratification variables by including a
“intervention by subgroup” interaction term in the model. We
present the hazard ratios and 95% confidence intervals for the
intervention effects within each of the subgroups, along with
the P values for the intervention by subgroup interaction.
Weidentifiedpredictorsofsuccessfulselfmanagementinitially
fromunivariatelogisticregressionmodels.Wetheninvestigated
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RESEARCHmultivariately those variables identified as significant at the
univariate level. A backwards stepwise selection method
identified those variables that were independently associated
with successful self management. Within the intervention arm
of the study, we compared successful and unsuccessful self
managers in terms of the study outcomes, using the methods
detailed above.
Results
BetweenJune2007andMay20091405patientswerescreened,
and, of 995 eligible cases, 464 (47%) were randomised to the
study (fig 1⇓). Median time to randomisation from the time of
dischargefromhospitalfortheindexexacerbationwas29days,
with no difference between groups. Intervention and control
groups were well matched for demographic and other variables
(table1⇓).Fifty-three(11%)patientsformallywithdrewduring
the study, which was completed in May 2010.
Primary end point
One hundred and eleven (48%) intervention participants and
108(47%)controlparticipantswerereadmittedtohospitalwith
COPD or died of COPD within 12 months. We found no
significant difference between groups in terms of the risk of
hospital admission or death due to COPD (hazard ratio 1.05,
95% confidence interval 0.80 to 1.38; P=0.73). In total, 39
deathsfromCOPDand52deathsfromallcausesoccurred,with
no significant differences in terms of risk between the groups
(table2⇓;fig2⇓).Thepre-plannedsubgroupanalysesalsofound
noevidenceofinterventioneffectsinanysubgroupofthestudy
population (fig 3⇓).
Secondary end points
Baselinequestionnairesandatleastonefollow-upquestionnaire
were available for 265 (61%) of the 433 patients still
participating in the study at the six month time point.
Participantswhofailedtoreturnquestionnairesweremorelikely
to be female, to be current smokers, to be living in areas of
greatestdeprivation,tohavebeenallocatedtothecontrolgroup,
ortohavehadahospitaladmissionduetoCOPDintheprevious
12 months. They were also less likely to have attended
pulmonaryrehabilitationinthetwoyearsbeforerandomisation.
Those who failed to return follow-up questionnaires had higher
baseline St George’s respiratory questionnaire impact
sub-scores,higherhospitalanxietyanddepressionscalescores,
and lower COPD self efficacy scores, indicative of greater
morbidity and less sense of self efficacy (web appendix B).
Ofthe265participantswhoreturnedbaselinequestionnaireand
at least one of the follow-up questionnaires, 150/232 (65%)
werefromtheinterventiongroupand115/232(50%)werefrom
the control group. The number of questionnaires available for
analysis varied between outcomes and time points owing to the
number of questionnaires returned and the completeness of the
returnedquestionnaires.DespitethelackofeffectonStGeorge’s
respiratory questionnaire symptom and activity sub-scores, we
saw a marked improvement in impacts sub-score in the
interventiongroup,contributingtoaborderlinesignificanteffect
of intervention on total St George’s respiratory questionnaire
score at 12 months (table 2⇓). Hospital anxiety and depression
scale anxiety score was also significantly improved at 12
months,althoughwefoundnosignificantdifferencesinhospital
anxiety and depression scale depression scores or COPD self
efficacy scores between the groups (table 2⇓).
Successful self management
Seventy-five (42%) of 180 intervention group participants who
completed 12 months’ follow-up were judged to have become
successful self managers; this group were younger, had lower
baseline COPD self efficacy scores (indicating lower self
efficacy), and were more likely to be living with others. Apart
from this, the groups were well matched for demographic and
diseaseseverityvariables(table3⇓).Theindependentpredictors
of successful self management identified from stepwise
modelling were younger age (P=0.012) and living with others
(P=0.010) (table 4⇓).
We found a significant reduction in readmissions among
successful self managers, compared with those in the
intervention group who did not master the technique (27% v
49%; hazard ratio 0.44, 0.25 to 0.76; P=0.003) (table 5⇓; fig
4⇓). This was associated with a difference in the time to first
exacerbation in favour of the successful group. We found no
significant difference in terms of all cause hospital admissions
(table 5⇓).
We also compared the primary end point between successful
selfmanagersandcontrolgroupparticipantswhocompleted12
months of follow-up because, although in the intention to treat
analysisparticipantsinthecontrolgrouphadareadmissionrate
of 47% (table 2⇓), this rate was 43% (75/174) for those who
completed the 12 months’ follow-up. These rates are similar to
those for the unsuccessful self managers. Comparison of the
primaryendpointofsuccessfulselfmanagersandcontrolgroup
participants completing the 12 month follow-up showed a
smaller but still significant benefit (hazard ratio 0.60, 0.36 to
0.99; P=0.045). Web appendix D shows the de novo analysis
of the primary end point for successful and unsuccessful self
managers with correction for possible confounding by all
stratification variables, COPD self efficacy score at baseline
and whether participants were living alone or with others; this
shows that the difference remained significant (P=0.03).
Discussion
In this study in the UK healthcare setting, supported self
management had no effect on readmissions or deaths due to
COPD and planned subgroup analyses showed no evidence of
a differential effect on outcome in relation to factors associated
with disease severity (FEV1 per cent predicted at the time of
randomisation,smokingstatus,numberofpreviousadmissions),
demographics (deprivation category of area of residence, age,
sex),orattendanceatpulmonaryrehabilitationwithintwoyears.
Although not pre-specified, we realised within the first six
monthsofrunningtheinterventionthatsomepatientsweremore
receptive to the concept of early recognition and treatment of
exacerbations. This allowed the study to be adapted so that
patients in the intervention group were classified at study exit
as successful self managers or not, by assessment of the
appropriateness of their use of treatment from review of diary
card records of symptoms in the days before they started
treatment. This classification was made independently of
information on readmissions to hospital. Exploratory analyses
showedthatsuccessfulselfmanagershadasignificantreduction
in the primary end point, and multivariate analysis showed that
successful self managers were more likely to be younger and
livingwithothers;otherpossibleconfoundersincludingsmoking
status were not significantly different (table 3⇓, web appendix
D).Successfulselfmanagershadsignificantlylower/worseself
efficacy scores at baseline, although this difference did not
survive multivariate analysis, suggesting that it was related to
the other variables.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e1060 doi: 10.1136/bmj.e1060 (Published 6 March 2012) Page 4 of 13
RESEARCHStrengths and weaknesses of study
Therobuststudydesign,thelargecohortthatallowedsubgroup
analyses, and the use of record linked data from all hospital
admissions in Scotland for all randomised cases are important
positive features of this study. The low participation rate (47%)
theoreticallylimitsthegeneralisabilityofthefindings.However,
giventhecommitmentneededfrompatientstoactivelymonitor
their condition and adjust treatment within the study, patients
not agreeing to participate in a trial of this design would
probably not be more likely to benefit than those studied. Web
appendix C shows the limited comparison possible on
demographic data of patients who participated and those who
declined, showing that participants were slightly younger on
average (mean age 69 v 70 years; P=0.07) and were less likely
to be living in the most highly deprived areas of residence;
despite this, 61% of the study population came from the most
deprivedareas(61%indeprivationcategories6and7,compared
with69%ofnon-participants;P=0.02).Nevertheless,giventhat
the primary analysis was negative and none of the pre-planned
subgroup analyses found any evidence of benefit,
non-participation is unlikely to have biased this result. Our
recruitment rate, at 47% of eligible patients, was similar to that
reported in previous studies (for example, 41% in Bourbeau et
al,
1549%inRiceetal
21),sothatthisproblemappliestotheentire
literature, an aspect of methodology not covered in the recent
Cochrane review.
2 The findings of our study in terms of
participation rates and lack of effect on important outcomes
highlight the fact that this practice cannot be recommended for
the generality of COPD cases of this level of severity in the UK
healthcare setting.
Completion rates for study questionnaires were also
disappointing and were lower in the control arm of the study.
Consequently, the apparent improvements in the intervention
arm(impactssubscaleofStGeorge’srespiratoryquestionnaire,
hospital anxiety and depression scale anxiety) could be biased,
and these results cannot be taken as convincing evidence in
favour of the intervention.
Differences between this and other studies
This study has not shown an effect on readmissions to hospital
withsupportedselfmanagement,atvariancewiththeconclusion
of the recent Cochrane review,
2 which included several smaller
negative studies. Our study was adequately powered for the
primary end point, and the study population was very similar
to those of previously reported positive studies in terms of
reported FEV1 and other disease related variables.
15 21 Our
control and intervention groups were well matched in terms of
importantvariablessuchasfemalesex,
22depression,
23andliving
alone.
24Comparingsocioeconomicdeprivationbetweenstudies
in different countries is difficult, but our intervention was
applied to a representative group of patients living in highly
deprived areas where COPD is known to be concentrated.
8 9
Several possible reasons could explain why this study did not
reproducethewholegroupbenefitsseeninotherrecentstudies:
differences in interventions and reporting of outcomes, in
healthcare systems, in the eligibility of patients for studies, and
in the effectiveness of the intervention itself. Rice et al had a
combined end point of emergency department visit or
readmission to hospital, with no significant benefit in terms of
readmission alone.
21 In the UK, the equivalents to emergency
departments are accident and emergency and out of hours
services;ourparticipantsreportedlowusageoftheseservices—a
median of 0 (range 0-3) visits to accident and emergency and
0(0-8)outofhourscontactsoverthe12monthfollow-upperiod,
with no differences between groups. In terms of intervention
differences, Bourbeau et al’s intervention included an exercise
component,
15 whereas we used stratification on the basis of
recent attendance at pulmonary rehabilitation to control for the
known beneficial effects of such rehabilitation.
25 The effect of
differences in healthcare systems is beyond the scope of this
paper, but factors such as payment structures, incentives, and
the characteristics of patients who are eligible for such
interventions in different healthcare systems may well be
important. The observation from this study that an intervention
which has been shown to be effective in other settings has not
produced the same benefits in the UK underscores the possible
effect of such factors.
With regard to the efficacy of the intervention reported here,
training was well structured (box 2), with didactic teaching,
interactiveexercises,anddiscussion,coupledwithfeedbackon
use of skills in a real life interaction by one trainer (JC) using
a structured method of feedback.
26 27 All study nurses were
assessed as competent before they were allocated patients to
support, and the observation that the intervention produced an
effectinasubstantialsubgroupofpatientsarguesforitsefficacy.
What this study adds
This study clearly casts doubt on the effectiveness of the
wholesale introduction of supported self management in the
UK healthcare setting. It provides important subgroup analyses
that show no difference in effect of the intervention in relation
topreviouslyrecognisedfactorsassociatedwithdiseaseseverity
or with demographic variables. The finding that only 42% of
intervention group patients learnt to self manage, and that this
subgroup had a significant reduction in the primary end point,
extends our current understanding of the possible effect of
supported self management. Bischoff et al reported a similar
level of effective use of a self management plan in a nested
study of exacerbations occurring during a rehabilitation trial in
Canada,
28 where younger age, coexisting cardiac disease, and
uptakeofinfluenzavaccinationweretheindependentpredictors
of adherence to self management plans. Together, these studies
begintheprocessofdefiningthecharacteristicsofpatientswho
may benefit from training and support in self management.
Unanswered questions and future research
Our findings show that supported self management cannot be
recommended for the generality of COPD patients treated for
exacerbated symptoms in the UK setting. The finding that a
significant minority of patients do derive benefit from this
intervention must be regarded as hypothesis generating, and
further investigation of the characteristics of successful self
managers is needed. Understanding this will help clinicians to
target limited resources efficiently and effectively, and, by
exploring the nature of this population further, we may be able
toidentifyhowbesttosupportthosepatientswhodonotbenefit
from self management. Further study of the characteristics of
successful self managers should allow predictive tools for this
and for the objective measurement of efficacy to be created.
Conclusions
This study found that supported self management had no effect
on readmissions to hospital or death due to COPD in a large
representative group of patients in the west of Scotland.
Subgroup analysis showed no differential effect in relation to
knownfactorsofdiseaseseverityordemographics.Exploratory
analyses showed that only 42% of the intervention group were
classified as successful self managers at the end of the study
period (12 months) on the basis of their recognition and
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RESEARCHappropriate use of treatment, and this subgroup had a
significantly reduced risk of readmission or death. Predictors
of successful self management are now emerging from this and
other studies, and this analysis shows that younger patients and
those not living alone are more likely to use self management
techniques and derive benefit from them.
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RESEARCHWhat is already known on this topic
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are debilitating for the patient and expensive for the health
service
Limited self management advice is ineffective in COPD
The latest Cochrane review concluded that “supported self management” (a combination of self management training and ongoing
support) shows benefit
What this study adds
No reduction in hospital admissions was seen with supported self management in COPD in the UK
No differential effect in relation to factors associated with the disease itself or demographics was apparent
Subgroup analysis showed that 42% of the intervention group learnt to self manage effectively and had significantly reduced risk of
readmission to hospital
Tables
Table 1| Baseline characteristics of participants. Values are numbers (percentages) unless stated otherwise
All (n=464) Control (n-232) Intervention (n=232) Characteristic
69.1 (9.3) 68.3 (9.2) 70.0 (9.3) Mean (SD) age (years)
170 (37) 82 (35) 88 (38) Male sex
40.5 (13.6) 39.8 (13.8) 41.2 (13.4) Mean (SD) % predicted FEV1
188 (41) 96 (41) 92 (40) Living alone
283 (61) 140 (60) 143 (62) Living in most deprived areas (deprivation categories 6 and 7)
181 (39) 91 (39) 90 (39) Current smoker
130 (28) 65 (28) 65 (28) Pulmonary rehabilitation attendance within 2 years of study entry
272 (59) 137 (59) 135 (58) Previous hospital admission for COPD in 12 months before index admission
4.36 (3.26) 4.46 (3.15) 4.26 (3.38) Mean (SD) No of self reported prednisolone courses in previous 12 months
2.8 (1.9) 2.8 (1.8) 2.9 (2.0) Mean (SD) No of comorbidities
426 (92) 211 (91) 215 (93) At least 1 comorbidity
34 (7) 18 (8) 16 (7) Long term oxygen at home
70.1 (16.4) 69.7 (16.1) 70.5 (16.7) Mean (SD) St George’s respiratory questionnaire total score.
69.0 (26.5) 69.8 (25.5) 68.2 (27.5) Mean (SD) COPD self efficacy score
9.7 (4.6) 9.3 (4.6) 10.0 (4.5) Mean (SD) hospital anxiety and depression scale anxiety score.
8.4 (4.0) 8.3 (4.1) 8.5 (3.9) Mean (SD) hospital anxiety and depression scale depression score.
COPD=chronic obstructive pulmonary disease; FEV1=forced expiratory volume in 1 second.
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RESEARCHTable 2| Primary and secondary* outcomes
P value Treatment effect† (95% CI) Control (n=232) Intervention (n=232) End point (at 12 months)
0.725 1.05 (0.80 to 1.38) 108 (47) 111 (48) No (%) COPD admission or COPD death
0.354 1.36 (0.71 to 2.61) 16 (7) 23 (10) No (%) COPD deaths
0.297 1.35 (0.77 to 2.38) 22 (9) 30 (13) No (%) deaths (all causes)
0.448 −2.17 (−7.80 to 3.46) −4.16 (22.52) (n=90) −6.01 (20.85) (n=116) Mean (SD) SGRQ symptom score
0.641 0.80 (−2.58 to 4.18) 0.95 (11.05) (n=69) 1.44 (13.27) (n=91) Mean (SD) SGRQ activity score
0.015 −6.89 (−12.40 to −1.39) 4.23 (15.51) (n=63) −3.16 (17.12) (n=78) Mean (SD) SGRQ impacts score
0.052 −4.52 (−9.07 to 0.04) 1.38 (11.33) (n=53) −2.99 (12.56) (n=69) Mean (SD) SGRQ total score
0.206 1.71 (0.75 to 3.89) (OR) 18/53 (34) 30/69 (43) No (%) with 4 point improvement in
SGRQ total score
0.540 2.65 (−5.85 to 11.14) −5.55 (33.72) (n=94) −1.73 (34.04) (n=119) Mean (SD) CSES total score
0.044 −1.06 (−2.08 to −0.03) 0.93 (3.29) (n=82) −0.37 (3.77) (n=104) Mean (SD) HADS anxiety score
0.538 −0.27 (−1.13 to 0.59) 0.75 (2.78) (n=84) 0.54 (3.26) (n=109) Mean (SD) HADS depression score
0.644 −6.9 (−36.1 to 22.4) 139.8 (100.3) (n=75) 132.8 (95.5) (n=107) Mean (SD) EQ-5D (area under curve)
COPD=chronic obstructive pulmonary disease; CSES=COPD self efficacy score; EQ-5D=EuroQol 5D; HADS=hospital anxiety and depression scale; SGRQ=St
George’s respiratory questionnaire.
*Numbers of paired datasets shown for each element.
†Mean differences or hazard ratios.
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RESEARCHTable 3| Comparison of baseline characteristics of “successful self managers” and others in intervention group. Values are numbers
(percentages) unless stated otherwise
All cases completing 12 months in
intervention group (n=180) Others (n=105) Successful self managers (n=75) Characteristic
69.5 (9.1) 71.2 (9.1) 67.3 (8.6) Mean (SD) age (years)*
72 (40) 40 (38) 32 (43) Male sex
41.6 (13.2) 40.9 (13.0) 42.6 (13.5) Mean (SD) % predicted FEV1
68 (38) 48 (46) 20 (27) Living alone*
114 (63) 65 (62) 49 (65) Living in most deprived areas (deprivation
categories 6 and 7)
69 (38) 44 (42) 25 (33) Current smokers
53 (29) 27 (26) 26 (35) Pulmonary rehabilitation attendance within 2 years
of study entry
94 (52) 54 (51) 40 (53) Hospital admission for COPD in year before study
entry
4.06 (3.33) 4.04 (3.45) 4.09 (3.18) Mean (SD) self reported prednisolone courses within
previous year
70.2 (17.5) (n=114) 68.3 (18.3) (n=67) 72.8 (16.1) (n=47) Mean (SD) SGRQ total score
70.8 (27.7) (n=152) 72.7 (30.2) (n=87) 68.3 (24.0) (n=65) Mean (SD) CSES total score*
9.7 (4.5) (n=135) 9.5 (4.4) (n=73) 10.0 (4.5) (n=62) Mean (SD) HADS anxiety score
8.2 (3.9) (n=140) 7.9 (4.1) (n=79) 8.7 (3.5) (n=61) Mean (SD) HADS depression score
COPD=chronic obstructive pulmonary disease; CSES=COPD self efficacy score; FEV1=forced expiratory volume in 1 second; HADS=hospital anxiety and depression
scale; SGRQ=St George’s respiratory questionnaire.
*Significant difference (P<0.05).
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RESEARCHTable 4| Predictors of successful self management
P value Odds ratio for success* (95% CI) Predictor
0.012 0.95 (0.91 to 0.99) Increasing age (years)
0.010 0.39 (0.19 to 0.80) Living alone
*Odds ratio <1 indicates lesser likelihood of success.
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RESEARCHTable 5| Healthcare outcomes, comparing successful self managers with unsuccessful self managers. Values are numbers (percentages)
unless stated otherwise
P value
Hazard ratio, SSM v non-SSM (95%
CI)
Unsuccessful self managers
(non-SSM) (n=105)
Successful self managers (SSM)
(n=75) End point (at 12 months)
0.003 0.44 (0.25 to 0.76) 51 (49) 20 (27) ≥1 hospital admission due to COPD
0.213 0.77 (0.52 to 1.16) 70 (67) 44 (59) ≥1 hospital admission (all causes)
COPD=chronic obstructive pulmonary disease.
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RESEARCHFigures
Fig 1 Flow of participants through study. AMT=abbreviated mental test; FVC=forced vital capacity; FEV1=forced expiratory
volume in 1 second; ISD=Information and Statistics Division
Fig 2 Hospital admissions and deaths due to chronic obstructive pulmonary disease, intervention versus control group
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RESEARCHFig 3 Subgroup analyses, intervention cohort: hazard ratios for readmission or death. COPD=chronic obstructive pulmonary
disease; DEPCAT=deprivation category of area of residence
10; FEV1=forced expiratory volume in 1 second; PR=pulmonary
rehabilitation
Fig 4 Readmissions for chronic obstructive pulmonary disease and deaths in successful self managers and others in
intervention group
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